US Archives -

News/ News/ News/ Patients/ Sales and Marketing

US government buys 66m doses of Moderna’s Omicron booster

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Moderna, Omicron, Pfizer, US 0 Comment

The Biden administration has confirmed its plans to start a booster vaccination campaign in the autumn, and placed

US government buys 66m doses of Moderna’s Omicron booster

https://pharmaphorum.com/news/us-government-buys-66m-doses-of-modernas-omicron-booster/

News/ News/ News/ Oncology/ Sales and Marketing

Merck sees big lift in Keytruda sales, as Senate probes its taxes

Phil Taylor Financial, Gardasil, Keytruda, Lagevrio, Merck & Co, tax, US 0 Comment

Merck & Co has reported record sales of its cancer immunotherapy Keytruda in the second quarter, as members

Merck sees big lift in Keytruda sales, as Senate probes its taxes

https://pharmaphorum.com/news/merck-sees-big-lift-in-keytruda-sales-as-senate-probes-its-taxes/

News/ News/ Sales and Marketing

AbbVie shielded profits from tax, says Senate panel

Phil Taylor AbbVie, Financial, Humira, Sales and Marketing, tax, US 0 Comment

A report by the Senate Finance Committee has concluded that AbbVie exploited a financial loophole introduced by former

AbbVie shielded profits from tax, says Senate panel

https://pharmaphorum.com/news/abbvie-shielded-profits-from-tax-says-senate-panel/

News/ News/ News/ Patients/ Sales and Marketing

Big three distributors claim win in $2.5bn WV opioid case

Phil Taylor AmerisourceBergen, Cardinal Health, liability, litigation, McKesson, opioid crisis, US 0 Comment

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not

Big three distributors claim win in $2.5bn WV opioid case

https://pharmaphorum.com/news/big-three-distributors-claim-win-in-2-5bn-wv-opioid-case/

News/ News/ News/ Patients/ Sales and Marketing

Pfizer claims new $3.2bn COVID jab deal with US government

Phil Taylor BioNTech, coronavirus, COVID-19, COVID-19 vaccine, Omicron, Pfizer, procurement, US 0 Comment

Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines,

Pfizer claims new $3.2bn COVID jab deal with US government

https://pharmaphorum.com/news/pfizer-claims-new-3-2bn-covid-jab-deal-with-us-government/

Market Access/ Views & Analysis/ Views and analysis

US frets over pharma supply chain security

Ben Hargreaves biologics, China, fda, pharma, US 0 Comment

The pandemic highlighted how fragile the global manufacturing network is, as supply of certain products was limited and

US frets over pharma supply chain security

https://pharmaphorum.com/market-access-2/us-frets-over-pharma-supply-chain-security/

News/ News/ Sales and Marketing

US meds spending spiked last year, but will fall quickly

Phil Taylor COVID-19, IQVIA, medicines spending, US 0 Comment

Prescription drug use in the US soared last year, as might be expected during a pandemic, but is

US meds spending spiked last year, but will fall quickly

https://pharmaphorum.com/news/us-meds-spending-spiked-last-year-but-will-fall-quickly/

News/ News/ Patients

US study finds high rates of unneeded antibiotic prescribing

Phil Taylor antibiotic, antimicrobial resistance, patients, prescribing, US 0 Comment

A study has found that there is still a very high level of inappropriate antibiotic prescribing to patients

US study finds high rates of unneeded antibiotic prescribing

https://pharmaphorum.com/news/us-study-finds-high-rates-of-unneeded-antibiotic-prescribing/

News/ News/ Sales and Marketing

Insulin price caps on the horizon as Senate leader plans vote

Phil Taylor Diabetes, Drug pricing, insulin, legislation, US 0 Comment

The US Senate will vote in the coming weeks on whether to introduce a $35 cap on the

Insulin price caps on the horizon as Senate leader plans vote

https://pharmaphorum.com/news/insulin-price-caps-on-the-horizon-as-senate-leader-plans-vote/

Trending

US

Login